Cargando…

Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment

The early diagnosis of Alzheimer's disease (AD) and mild cognitive impairment (MCI) is very important for treatment research and patient care purposes. Few biomarkers are currently considered in clinical settings, and their use is still optional. The objective of this work was to determine whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Torteya, Antonio, Treviño, Víctor, Tamez-Peña, José G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464003/ https://www.ncbi.nlm.nih.gov/pubmed/26106620 http://dx.doi.org/10.1155/2015/961314

Ejemplares similares

Signal and Texture Features from T2 Maps for the Prediction of Mild Cognitive Impairment to Alzheimer’s Disease Progression
por: Trejo-Castro, Alejandro I., et al.
Publicado: (2021)

Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012)

Bilateral Image Subtraction and Multivariate Models for the Automated Triaging of Screening Mammograms
por: Celaya-Padilla, José, et al.
Publicado: (2015)

SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
por: Aguirre-Gamboa, Raul, et al.
Publicado: (2013)

Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
por: Young, Jonathan, et al.
Publicado: (2013)

Improving predictive models for Alzheimer’s disease using GWAS data by incorporating misclassified samples modeling
por: Romero-Rosales, Brissa-Lizbeth, et al.
Publicado: (2020)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
por: Bauer, Corinna M., et al.
Publicado: (2018)

The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis
por: Xing, Wenmin, et al.
Publicado: (2021)

Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer’s disease using multimodal data
por: Kikuchi, Masataka, et al.
Publicado: (2022)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Yamada, Yasunori, et al.
Publicado: (2021)

Inclusion of Neuropsychological Scores in Atrophy Models Improves Diagnostic Classification of Alzheimer's Disease and Mild Cognitive Impairment
por: Goryawala, Mohammed, et al.
Publicado: (2015)

Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients
por: Wittenberg, Raphael, et al.
Publicado: (2019)

Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer’s Disease Biomarker and Mild Cognitive Impairment Diagnoses
por: Nation, Daniel A., et al.
Publicado: (2019)

Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease
por: Popescu, Sebastian G., et al.
Publicado: (2020)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

A multi-regression framework to improve diagnostic ability of optical coherence tomography retinal biomarkers to discriminate mild cognitive impairment and Alzheimer’s disease
por: Chua, Jacqueline, et al.
Publicado: (2022)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers
por: Jang, Hyemin, et al.
Publicado: (2019)

Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease
por: Fornari, Chiara, et al.
Publicado: (2022)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer’s disease
por: Lad, Eleonora M., et al.
Publicado: (2018)

Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease
por: Tao, Rui, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer’s disease and mild cognitive impairment
por: Castellazzi, Massimiliano, et al.
Publicado: (2019)

Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease
por: Oviedo, Diana C., et al.
Publicado: (2018)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
por: Arenare, Giulia, et al.
Publicado: (2023)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Apathy and Leukoaraiosis in Mild Cognitive Impairment and Alzheimer's Disease: Multicenter Diagnostic Criteria according to the Latest Studies
por: Sarabia-Cobo, Carmen María, et al.
Publicado: (2014)

MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
por: Richard, Edo, et al.
Publicado: (2013)

P-tau231 as a Diagnostic Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Assessment for apraxia in mild cognitive impairment and Alzheimer's dise
por: Ward, Mirela, et al.
Publicado: (2015)

Multimodal MRI for early diabetic mild cognitive impairment: study protocol of a prospective diagnostic trial
por: Yu, Ying, et al.
Publicado: (2016)

Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's disease
por: Hendrix, Suzanne B, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9qf27js5lscqv472feq36qqb3r